Cargando…
Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report
BACKGROUND: Being expressed in all stages of B-cell development and having a significant value on the European Group for the Immunological Characterization of Acute Leukemias scoring system, CD79a is considered as an excellent pan-marker for lineage assignment of B cells by flow cytometry. Therefore...
Autores principales: | Berhili, A., Bensalah, M., ElMalki, J., Elyagoubi, A., Seddik, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555128/ https://www.ncbi.nlm.nih.gov/pubmed/34706776 http://dx.doi.org/10.1186/s13256-021-03128-2 |
Ejemplares similares
-
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
por: Sinclair, Paul. B., et al.
Publicado: (2018) -
Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases
por: Mroczkowska, Aleksandra, et al.
Publicado: (2021) -
Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia
por: Duployez, Nicolas, et al.
Publicado: (2015) -
Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016) -
Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too?
por: Al-Sweedan, Suleimman, et al.
Publicado: (2019)